synthego.comHealthcareFounded: 2012Funding to Date: $415.07MM
Synthego, founded in 2012 by Paul and Michael Dabrowski, is a genome engineering company leveraging machine learning, automation, and gene editing to build platforms for science at scale. Synthego is setting out to accelerate CRISPR research, a genome engineering technique that could help cure genetic diseases or even bring back woolly mammoths from extinction. Synthego is headquartered in Redwood City, CA.
